Nanozymes for Non-Neoplastic Diseases: Catalytic Therapy Redefined

Abstract

Non-neoplastic diseases, such as cardiovascular, neurodegenerative, metabolic, and inflammatory disorders, are major global health challenges with complex pathophysiologies that demand precise and innovative therapeutic strategies. Nanozymes, artificial nanomaterials with enzyme-like catalytic functions, have recently emerged as promising candidates for such interventions. Distinguished by their programmable structures, tunable activities, and excellent biocompatibility, nanozymes can mimic multiple natural enzymes (e.g., superoxide dismutase, catalase, and peroxidase) to modulate oxidative stress and inflammation. Beyond catalytic activity, their functional integration enables immune regulation and metabolic reprogramming, facilitating multilevel (molecular to tissue) microenvironmental remodeling. This review highlights recent progress in nanozyme development for non-neoplastic disease therapy, emphasizing structure–function relationships, activity regulation in pathological conditions, and mechanistic roles in disrupting the oxidative stress–inflammation–immune dysregulation loop. We further summarize representative applications across cardiovascular diseases, neurodegenerative conditions, metabolic disorders, and inflammatory pathologies, focusing on advances in targeted delivery, responsive release, and multimodal theranostics. These insights collectively underline the transformative potential of nanozymes in next-generation precision medicine.

Keywords

inflammation / nanozymes / non-neoplastic diseases / reactive oxygen species / theranostics

References

[1] J. Doroszkiewicz, J. Mroczko, I. Winkel, and B. Mroczko, “Metabolic and Immune System Dysregulation: Unraveling the Connections Between Alzheimer's Disease, Diabetes, Inflammatory Bowel Diseases, and Rheumatoid Arthritis,” Journal of Clinical Medicine 13 (2024): 5057.

[2] A. Wang, B. Guan, H. Zhang, and H. Xu, “Danger-Associated Metabolites Trigger Metaflammation: A Crowbar in Cardiometabolic Diseases,” Pharmacological Research 198 (2023): 106983.

[3] E. Domingo, P. Marques, V. Francisco, L. Piqueras, and M. J. Sanz, “Targeting Systemic Inflammation in Metabolic Disorders. A Therapeutic Candidate for the Prevention of Cardiovascular Diseases?,” Pharmacological Research 200 (2024): 107058.

[4] G. Xiao, H. Li, Y. Zhao, et al., “Nanoceria-Based Artificial Nanozymes: Review of Materials and Applications,” ACS Applied Nano Materials 5 (2022): 14147.

[5] F. Cheng, S. Kotha, M. Fu, et al., “Nanozyme Enabled Protective Therapy for Neurological Diseases,” Nano Today 54 (2024): 102142.

[6] Y. Zhang, W. Liu, X. Wang, Y. Liu, and H. Wei, “Nanozyme-Enabled Treatment of Cardio- and Cerebrovascular Diseases,” Small 19 (2023): e2204809.

[7] H. Wang, Z. Cui, X. Wang, S. Sun, D. Zhang, and C. Fu, “Therapeutic Applications of Nanozymes in Chronic Inflammatory Diseases,” BioMed Research International 2021 (2021): 9980127.

[8] L. Yang, S. Dong, S. Gai, et al., “Deep Insight of Design, Mechanism, and Cancer Theranostic Strategy of Nanozymes,” Nano-Micro Letters 16 (2023): 28.

[9] S. Cao, S. Dong, L. Feng, et al., “Engineering Strain-Defects to Enhance Enzymatic Therapy and Induce Ferroptosis,” Advanced Materials 36 (2024): e2408502.

[10] Z. Chen, B. Li, Y. Zhang, et al., “Bioinspired Rational Design of Nanozymes,” Materials Horizons 12 (2025): 5957–5974.

[11] Q. Ding, L. Ding, C. Xiang, et al., “pH-Responsive AIE Photosensitizers for Enhanced Antibacterial Therapy,” Angewandte Chemie International Edition 64 (2025): e202506505.

[12] L. Gu, Y. Sun, T. Bai, et al., “Functional Nanozyme System for Synergistic Tumor Immunotherapy via Cuproptosis and Ferroptosis Activation,” Journal Nanobiotechnology 23 (2025): 212.

[13] H. Wang, Y. Yang, H. Yu, et al., “Self-Cascade API Nanozyme for Synergistic Anti-Inflammatory, Antioxidant, and Ferroptosis Modulation in the Treatment of Corneal Neovascularization,” Small 21 (2025): e2407751.

[14] Q. Ding, J. Liu, Y. Wang, et al., “Dual-laser “808 and 1,064 Nm” Strategy That Circumvents the Achilles' heel of Photothermal Therapy,” Proceedings of the National Academy of Sciences of the United States of America 122 (2025): e2503574122.

[15] L. Rao, Y. Yuan, X. Shen, G. Yu, and X. Chen, “Designing Nanotheranostics With Machine Learning,” Nature Nanotechnology 19 (2024): 1769–1781.

[16] A. Mohapatra and I. K. Park, “Recent Advances in ROS-Scavenging Metallic Nanozymes for Anti-Inflammatory Diseases: A Review,” Chonnam Medical Journal 59 (2023): 13.

[17] Q. Ding, C. Wang, H. Wang, et al., “Rabies Virus Targeting NIR-II Phototheranostics,” Journal of the American Chemical Society 147 (2025): 16661–16673.

[18] Y. Ju, X. Liu, X. Ye, et al., “Nanozyme-Based Remodeling of Disease Microenvironments for Disease Prevention and Treatment: A Review,” ACS Applied Nano Materials 6 (2023): 13792–13823.

[19] L. Gao, J. Zhuang, L. Nie, et al., “Intrinsic Peroxidase-Like Activity of Ferromagnetic Nanoparticles,” Nature Nanotechnology 2 (2007): 577–583.

[20] R. Fu, Z. Ma, H. Zhao, et al., “Research Progress in Iron-Based Nanozymes: Catalytic Mechanisms, Classification, and Biomedical Applications,” Analytical Chemistry 95 (2023): 10844–10858.

[21] Z. Wang, R. Zhang, X. Yan, and K. Fan, “Structure and Activity of Nanozymes: Inspirations for De Novo Design of Nanozymes,” Materials Today 41 (2020): 81–119.

[22] C. Xie, J. Liao, Y. Li, et al., “Synergistic Anti-Inflammatory Effect of Cascade Nanozymes for Neural Recovery in Ischemic Stroke,” Chinese Chemical Letters (2025): 110956.

[23] J. Han, Y. S. Kim, M.-Y. Lim, et al., “Dual Roles of Graphene Oxide To Attenuate Inflammation and Elicit Timely Polarization of Macrophage Phenotypes for Cardiac Repair,” ACS Nano 12 (2018): 1959–1977.

[24] Q. Ding, S. Huang, Z. Zhang, et al., “Integration of Photodiagnosis and Therapy Guided by Micro/Nanorobots,” Advanced Materials 37 (2025): e2420359.

[25] L. Fan, P. Sun, Y. Huang, et al., “One-Pot Synthesis of Fe/N-Doped Hollow Carbon Nanospheres With Multienzyme Mimic Activities Against Inflammation,” ACS Applied Bio Materials 3 (2020): 1147–1157.

[26] Q. Ding, H. Rha, C. Yoon, et al., “Regulated Cell Death Mechanisms in Mitochondria-targeted Phototherapy,” Journal of Controlled Release 382 (2025): 113720.

[27] B. Xue, Y. Lu, S. Wang, et al., “The Emerging Role of Nanozymes in Ocular Antioxidant Therapy,” Nano Today 58 (2024): 102448.

[28] L. Mei, Q. Ding, Y. Xie, et al., “Self-propelling Intelligent Nanomotor: A Dual-action Photothermal and Starvation Strategy for Targeted Deep Tumor Destruction,” Biomaterials 315 (2025): 122968.

[29] J. Wu, X. Wang, Q. Wang, et al., “Nanomaterials With Enzyme-Like Characteristics (nanozymes): Next-generation Artificial Enzymes (II),” Chemical Society Reviews 48 (2019): 1004–1076.

[30] M. Kluenker, M. Nawaz Tahir, R. Ragg, et al., “Pd@Fe 2 O 3 Superparticles With Enhanced Peroxidase Activity by Solution Phase Epitaxial Growth,” Chemistry of Materials 29 (2017): 1134–1146.

[31] G. Bardi, L. Boselli, and P. P. Pompa, “Anti-inflammatory Potential of Platinum Nanozymes: Mechanisms and Perspectives,” Nanoscale 15 (2023): 14284–14300.

[32] H. Xia, N. Li, X. Zhong, and Y. Jiang, “Metal-Organic Frameworks: A Potential Platform for Enzyme Immobilization and Related Applications,” Frontiers in Bioengineering and Biotechnology 8 (2020): 695.

[33] X. Liu, H. Zhang, C. Hao, H. Kuang, C. Xu, and L. Xu, “Chiral Se@CeO 2 Superparticles for Ameliorating Parkinson's Disease,” Nanoscale 15 (2023): 4367–4377.

[34] N. Singh, M. A. Savanur, S. Srivastava, P. D'Silva, and G. Mugesh, “A Redox Modulatory Mn 3 O 4 Nanozyme With Multi-Enzyme Activity Provides Efficient Cytoprotection to Human Cells in a Parkinson's Disease Model,” Angewandte Chemie International Edition 56 (2017): 14267–14271.

[35] L. Wang, X. Yuan, Q. Cai, et al., “Mitochondria-Targeting Cu2-xSe-TPP With Dual Enzyme Activity Alleviates Alzheimer's Disease by Modulating Oxidative Stress,” Colloids and Surfaces B 245 (2025): 114244.

[36] K. Xiang, H. Wu, Y. Liu, et al., “MOF-derived Bimetallic Nanozyme to Catalyze ROS Scavenging for Protection of Myocardial Injury,” Theranostics 13 (2023): 2721–2733.

[37] S. Feng, X. Peng, Y. Deng, et al., “Biomimetic Nanozyme-Decorated Smart Hydrogel for Promoting Chronic Refractory Wound Healing,” American Chemical Society Applied Materials & Interfaces 16 (2024): 59862–59879.

[38] F. Wang, H. Yuan, J. Shen, et al., “Nanozymes With Broad-Spectrum Scavenging of Reactive Oxygen Species (ROS) Alleviate Inflammation in Acute Liver Injury,” ACS Materials Letters 6 (2024): 1304–1316.

[39] M. Mao, X. Guan, F. Wu, and L. Ma, “CoO Nanozymes With Multiple Catalytic Activities Regulate Atopic Dermatitis,” Nanomaterials 12 (2022): 638.

[40] S. Dai, L. Yao, L. Liu, et al., “Carbon Dots-supported Zn Single Atom Nanozymes for the Catalytic Therapy of Diabetic Wounds,” Acta Biomaterialia 186 (2024): 454–469.

[41] R. Hu, C. Dai, C. Dong, et al., “Living Macrophage-Delivered Tetrapod PdH Nanoenzyme for Targeted Atherosclerosis Management by ROS Scavenging, Hydrogen Anti-inflammation, and Autophagy Activation,” ACS Nano 16 (2022): 15959–15976.

[42] W.-C. Luo, L.-N. Bao, Y. Zhang, et al., “A Ru³⁺-functionalized-NMOF Nanozyme as an Inhibitor and Disaggregator of β-amyloid Aggregates,” Journal of Materials Chemistry B 12 (2024): 12239–12250.

[43] H. Xu, X. Ding, L. Li, Q. Li, Z. Li, and H. Lin, “Tri-element Nanozyme PtCuSe as an Ingenious Cascade Catalytic Machine for the Amelioration of Parkinson's Disease-Like Symptoms,” Frontiers in Bioengineering and Biotechnology 11 (2023): 1208693.

[44] L. Zhang, A. Li, M. Shen, Z. Zhang, R. Wufuer, and D. Wang, “Palladium–platinum Bimetallic Modified MXene Nanozyme for Highly Sensitive Detection of Active Substances With Acetylcholinesterase Inhibitory Effect,” Talanta 282 (2025): 127020.

[45] S. Chen, X. Luo, Y. Sun, W. Jin, and R. He, “A Novel Metabolic Reprogramming Strategy for the Treatment of Targeting to Heart Injury-mediated Macrophages,” International Immunopharmacology 122 (2023): 110377.

[46] L. Wang, Z. Gao, M. Tian, et al., “A Nanosystem Alleviates Severe Acute Pancreatitis via Reactive Oxygen Species Scavenging and Enhancing Mitochondrial Autophagy,” Nano Letters 25 (2025): 8644–8654.

[47] Q. Li, X. Ding, Z. Chang, et al., “Metal–Organic Framework Based Nanozyme System for NLRP3 Inflammasome-Mediated Neuroinflammatory Regulation in Parkinson's Disease,” Advanced Healthcare Materials 13 (2023): 2303454.

[48] Y. Liu, Y. Cheng, H. Zhang, et al., “Integrated Cascade Nanozyme Catalyzes in Vivo ROS Scavenging for Anti-inflammatory Therapy,” Science Advances 6 (2020): eabb2695.

[49] C. Liu, W. Zhang, H. Zhang, et al., “Biomimetic Engineering of a Neuroinflammation-targeted MOF Nanozyme Scaffolded With Photo-trigger Released CO for the Treatment of Alzheimer's Disease,” Chemical Science 15 (2024): 13201–13208.

[50] X. Liu, B. Chen, J. Chen, et al., “A Cardiac-Targeted Nanozyme Interrupts the Inflammation-Free Radical Cycle in Myocardial Infarction,” Advanced Materials 36 (2023): 2308477.

[51] D. Xu, L. Wu, H. Yao, and L. Zhao, “Catalase-like Nanozymes: Classification, Catalytic Mechanisms, and Their Applications,” Small 18 (2022): e2203400.

[52] S. Li, H. Ding, J. Chang, et al., “Bimetallic Oxide Nanozyme-mediated Depletion of Glutathione to Boost Oxidative Stress for Combined Nanocatalytic Therapy,” Journal of Colloid & Interface Science 623 (2022): 787–798.

[53] Q. Ding, H. Chen, Y. Zhang, et al., “Innovative Integration of Nanomedicines and Phototherapy to Modulate Autophagy for Enhanced Tumor Eradication,” Journal of Controlled Release 377 (2025): 855–879.

[54] J. Xiang, X. Yang, M. Tan, et al., “NIR-enhanced Pt single atom/g-C(3)N(4) nanozymes as SOD/CAT mimics to rescue ATP energy crisis by regulating oxidative phosphorylation pathway for delaying osteoarthritis progression,” Bioactive Materials 36 (2024): 1.

[55] J. Zhang, Z. Wang, X. Lin, et al., “Mn−Ce Symbiosis: Nanozymes with Multiple Active Sites Facilitate Scavenging of Reactive Oxygen Species (ROS) Based on Electron Transfer and Confinement Anchoring,” Angewandte Chemie International Edition 64 (2025): e202416686.

[56] Y. Wang, Q. Ding, G. Ma, et al., “Mucus-Penetrable Biomimetic Nanoantibiotics for Pathogen-Induced Pneumonia Treatment,” ACS Nano 18 (2024): 31349–31359.

[57] B. C. Yan, J. Cao, J. Liu, et al., “Dietary Fe₃O₄ Nanozymes Prevent the Injury of Neurons and Blood–Brain Barrier Integrity From Cerebral Ischemic Stroke,” ACS Biomaterials Science & Engineering 7 (2021): 299–310.

[58] X. Lei, l. Qiu, and F. Du, “ZIF-8@Pt Nanozyme Used for Scavenging Reactive Oxygen Species in the Treatment of Rheumatoid Arthritis,” Journal of Sichuan University Medical Science 55 (2024): 826.

[59] Z. Gu, D. Zhong, X. Hou, et al., “Unraveling Ros Conversion through Enhanced Enzyme-like Activity With Copper-Doped Cerium Oxide for Tumor Nanocatalytic Therapy,” Advanced Science 11 (2023): 2307154.

[60] H. Ruan, S. Zhang, H. Wang, et al. Nano Mater 5 (2022): 6564.

[61] L. Jiao, W. Xu, Y. Zhang, et al., “Boron-doped Fe-N-C Single-atom Nanozymes Specifically Boost Peroxidase-Like Activity,” Nano Today 35 (2020): 100971.

[62] J. Dong, Z. Huang, Y. Fu, et al., “FeCu–P/Carbon Dots With Multi-enzyme Activity Catalyze Reactive Oxygen Species Production for Enhanced Antibacterial Activity,” Carbon 243 (2025): 120478.

[63] H. Cao, Y. Yuan, R. Zhao, et al., “Deciphering the Catalytic Mechanism of Peroxidase-Like Activity of Iron Sulfide Nanozymes,” American Chemical Society Applied Materials & Interfaces 16 (2024): 30958–30966.

[64] W. Feng, X. Han, H. Hu, et al., “2D vanadium Carbide MXenzyme to Alleviate ROS-mediated Inflammatory and Neurodegenerative Diseases,” Nature Communications 12 (2021): 2203.

[65] M. Mohsin, F. Shams, H. Li, et al., “Nanozymes in Neuropathic Pain: Strategies Bridging Oxidative Stress, Mitochondrial Repair, and Neuroimmune Modulation for Targeted Therapy,” Journal of Neuroinflammation 22 (2025): 156.

[66] Q. Ding, X. Xu, Y. Li, et al., “Diverse Interactions Between AIEgens and Biomolecules/Organisms: Advancing From Strategic Design to Precision Theranostics,” Chem 10 (2024): 2031–2073.

[67] MRK, D. Mehta, and S. Singh, “CeO₂ and Mn₃O₄-based nanozymes exhibit scavenging of singlet oxygen species and hydroxyl radicals,” Nanoscale 17 (2025): 18077–18082.

[68] J. Shi, Y. Zhang, X. Fang, et al., “Photoswitchable Antioxidant and Prooxidant Activities of Mg-Doped Carbon Dot Nanozymes as Antibacterial and Anti-Inflammatory Agents,” American Chemical Society Applied Materials & Interfaces 17 (2025): 26467–26479.

[69] S. Zhang, X. J. Gao, Y. Ma, et al., “A Bioinspired Sulfur–Fe–heme Nanozyme With Selective Peroxidase-Like Activity for Enhanced Tumor Chemotherapy,” Nature Communications 15 (2024): 10605.

[70] S. Shahraki, E. Vaziri, A. A. Saboury, and K. Fan, “Biomedical Potential of Nanozymes: Harnessing Redox Enzyme Mimicry for Theranostic Applications,” Coordination Chemistry Reviews 517 (2024): 215937.

[71] T. Liu, B. Xiao, F. Xiang, et al., “Ultrasmall Copper-based Nanoparticles for Reactive Oxygen Species Scavenging and Alleviation of Inflammation Related Diseases,” Nature Communications 11 (2020): 2788.

[72] W. Jiang, Q. Li, R. Zhang, et al., “Chiral Metal-organic Frameworks Incorporating Nanozymes as Neuroinflammation Inhibitors for Managing Parkinson's Disease,” Nature Communications 14 (2023): 8137.

[73] Y. Liu, Y. Liu, P. Shi, et al., “Single-atom Nanozyme Liposome-integrated Microneedles for in Situ Drug Delivery and Anti-inflammatory Therapy in Parkinson's Disease,” Journal of Nanbiotechnology 22 (2024): 643.

[74] X. Zhang, B. Liu, Y. Lu, Z. Liu, and J. Li, “Self-Propelled Peg-Fe₃O₄@ MnO₂ Janus Magnetic Nanorobots as Enzyme-Like for Dynamic Detection of Gsh and Efficient Degradation of Tch,” (2022): SSRN 4140964.

[75] F. Corsi, G. Deidda Tarquini, M. Urbani, I. Bejarano, E. Traversa, and L. Ghibelli, “The Impressive Anti-Inflammatory Activity of Cerium Oxide Nanoparticles: More Than Redox?,” Nanomaterials 13 (2023): 2803.

[76] J. Zeng, S. Huang, F. Du, et al., “Advances in the Application of Nanozymes in Joint Disease Therapy,” Journal of Sichuan University Medical Science 55 (2024): 800.

[77] Behzadi, S. Luther, G. A. Harris, et al., “Nanomedicine for Safe Healing of Bone Trauma: Opportunities and Challenges,” Biomaterials 146 (2017): 168–182.

[78] T. Meng, D. He, Z. Han, et al., “Nanomaterial-Based Repurposing of Macrophage Metabolism and Its Applications,” Nano-Micro Letters 16 (2024): 246.

[79] J. J. M. Lasola, A. L. Cottingham, B. L. Scotland, et al., “Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK,” Pharmaceutics 13 (2021): 1841.

[80] M. Repellin, H. Guerin, G. Catania, and G. Lollo, “ROS-based Nanomedicines for Anti-inflammatory Therapies,” Redox Experimental Medicine 2023 (2023): e230021.

[81] Y. Wu and H. T. Ta, “Different Approaches to Synthesising Cerium Oxide Nanoparticles and Their Corresponding Physical Characteristics, and ROS Scavenging and Anti-inflammatory Capabilities,” Journal of Materials Chemistry B 9 (2021): 7291–7301.

[82] S. Liang, X. Tian, and C. Wang, “Nanozymes in the Treatment of Diseases Caused by Excessive Reactive Oxygen Specie,” Journal of Inflammation Research 15 (2022): 6307–6328.

[83] H. Wei, H. Huang, H. He, et al., “Pt–Se Hybrid Nanozymes With Potent Catalytic Activities to Scavenge ROS/RONS and Regulate Macrophage Polarization for Osteoarthritis Therapy,” Research 7 (2024): 0310.

[84] X. Xu, Y. Zhang, C. Meng, et al., “Nanozymes in Cancer Immunotherapy: Metabolic Disruption and Therapeutic Synergy,” Journal of Materials Chemistry B 12 (2024): 9111–9143.

[85] Q. Ding, H. Liu, L. Yan, et al. Angewandte Chemie International Edition (2025): e202505911.

[86] J. Da, Y. Li, K. Zhang, et al., “Functionalized Prussian Blue Nanozyme as Dual-Responsive Drug Therapeutic Nanoplatform Against Maxillofacial Infection via Macrophage Polarization,” International Journal of Nanomedicine 17 (2022): 5851.

[87] S. Xu, Y. Zhang, X. Ding, et al., “Intestinal Microbiota Affects the Progression of Colorectal Cancer by Participating in the Host Intestinal Arginine Catabolism,” Cell Reports 44 (2025): 115370.

[88] Y. Xiang, M. Zhang, D. Jiang, Q. Su, and J. Shi, “The Role of Inflammation in Autoimmune Disease: A Therapeutic Target,” Frontiers in Immunology 14 (2023): 1267091.

[89] F. Shao, Q. Liu, Y. Zhu, et al., “Targeting Chondrocytes for Arresting Bony Fusion in Ankylosing Spondylitis,” Nature Communications 12 (2021): 6540.

[90] S.-J. Zhang, R. Xu, S.-B. He, et al. Military Medical Research 12 (2025): 27.

[91] Z. Fu, M. Zhang, Y. Huang, et al., “DNA Binding Effects of LDH Nanozyme for Aseptic Osteolysis Mitigation Through STING Pathway Modulation,” Journal of Nanbiotechnology 23 (2025): 384.

[92] X. Wu, M. Xu, M. Geng, et al., “Targeting Protein Modifications in Metabolic Diseases: Molecular Mechanisms and Targeted Therapies,” Signal Transduction and Targeted Therapy 8 (2023): 220.

[93] X. Zhang, Y. Qin, X. Wan, et al., “Rosuvastatin Exerts Anti-atherosclerotic Effects by Improving Macrophage-related Foam Cell Formation and Polarization Conversion via Mediating Autophagic Activities,” Journal of Translational Medicine 19 (2021): 62.

[94] Q. Chen, X. Duan, Y. Yu, et al., “Target Functionalized Carbon Dot Nanozymes With Dual-Model Photoacoustic and Fluorescence Imaging for Visual Therapy in Atherosclerosis,” Advanced Science 11 (2023): 2307441.

[95] F. Lv, H. Fang, L. Huang, et al., “Curcumin Equipped Nanozyme-like Metal−Organic Framework Platform for the Targeted Atherosclerosis Treatment With Lipid Regulation and Enhanced Magnetic Resonance Imaging Capability,” Advanced Science 11 (2024): 2309062.

[96] L. Wang, X. Zhang, H. Zhang, et al., “Novel Metal-Free Nanozyme for Targeted Imaging and Inhibition of Atherosclerosis via Macrophage Autophagy Activation to Prevent Vulnerable Plaque Formation and Rupture,” American Chemical Society Applied Materials & Interfaces 16 (2024): 51944–51956.

[97] C. Wang, Y. He, J. Tang, et al., “Chondroitin Sulfate Functionalized Nanozymes Inhibit the Inflammation Feedback Loop for Enhanced Atherosclerosis Therapy by Regulating Intercellular Crosstalk,” International Journal of Biological Macromolecules 282 (2024): 136918.

[98] S. Wang, J. Zhang, W. Li, et al., “Hyaluronic Acid-guided Assembly of Ceria Nanozymes as Plaque-targeting ROS Scavengers for Anti-atherosclerotic Therapy,” Carbohydrate Polymers 296 (2022): 119940.

[99] H. He, Q. Han, S. Wang, et al., “Design of a Multifunctional Nanozyme for Resolving the Proinflammatory Plaque Microenvironment and Attenuating Atherosclerosis,” ACS Nano 17 (2023): 14555–14571.

[100] Y. Zhong, Y. Yang, Y. Xu, et al., “Design of a Zn-based Nanozyme Injectable Multifunctional Hydrogel With ROS Scavenging Activity for Myocardial Infarction Therapy,” Acta Biomaterialia 177 (2024): 62–76.

[101] W. Yang, X. Li, J. Lei, et al., “Targeted Anti-Inflammatory Nanozymes With Pro-Angiogenic Activity for Myocardial Infarction Therapy,” Advanced Healthcare Materials 14 (2025): 2404979.

[102] Y. Lu, C. Cao, X. Pan, Y. Liu, and D. Cui, “Structure Design Mechanisms and Inflammatory Disease Applications of Nanozymes,” Nanoscale 15 (2023): 14–40.

[103] M. Ma, N. Gao, X. Li, et al., “A Biocompatible Second Near-Infrared Nanozyme for Spatiotemporal and Non-Invasive Attenuation of Amyloid Deposition Through Scalp and Skull,” ACS Nano 14 (2020): 9894–9903.

[104] Z. Jia, X. Yuan, J.-a. Wei, et al., “A Functionalized Octahedral Palladium Nanozyme as a Radical Scavenger for Ameliorating Alzheimer's Disease,” American Chemical Society Applied Materials & Interfaces 13 (2021): 49602–49613.

[105] M. Ma, Z. Liu, N. Gao, et al., “Self-Protecting Biomimetic Nanozyme for Selective and Synergistic Clearance of Peripheral Amyloid-β in an Alzheimer's Disease Model,” Journal of the American Chemical Society 142 (2020): 21702–21711.

[106] Y. Gong, A. Huang, X. Guo, et al., “Selenium-core Nanozymes Dynamically Regulates Aβ & Neuroinflammation Circulation: Augmenting Repair of Nervous Damage,” Chemical Engineering Journal 418 (2021): 129345.

[107] Y. E. Choonara, V. Pillay, L. C. Du Toit, et al., “Trends in the Molecular Pathogenesis and Clinical Therapeutics of Common Neurodegenerative Disorders,” International Journal of Molecular Sciences 10 (2009): 2510–2557.

[108] S. K. Beura, A. R. Panigrahi, P. Yadav, et al., “Harnessing Two-dimensional Nanomaterials for Diagnosis and Therapy in Neurodegenerative Diseases: Advances, Challenges and Prospects,” Ageing Research Reviews 94 (2024): 102205.

[109] X. Ma, J. Hao, J. Wu, Y. Li, X. Cai, and Y. Zheng, “Prussian Blue Nanozyme as a Pyroptosis Inhibitor Alleviates Neurodegeneration,” Advanced Materials 34 (2022): 2106723.

[110] W. Ji, Y. Li, H. Peng, et al., “Self-Catalytic Small Interfering RNA Nanocarriers for Synergistic Treatment of Neurodegenerative Diseases,” Advanced Materials 34 (2021): 2105711.

[111] F.-D. Shi and V. W. Yong, “Neuroinflammation Across Neurological Diseases,” Science 388 (2025): 6753.

[112] K. Zhang, M. Tu, W. Gao, et al., “Hollow Prussian Blue Nanozymes Drive Neuroprotection Against Ischemic Stroke via Attenuating Oxidative Stress, Counteracting Inflammation, and Suppressing Cell Apoptosis,” Nano Letters 19 (2019): 2812–2823.

[113] W. Huang, Y. Tian, J. Ma, et al., “Neutrophil Membrane-based Biomimetic Metal-polyphenol Self-assembled Nanozyme for the Targeting Treatment of Early Brain Injury Following Subarachnoid Hemorrhage,” Chemical Engineering Journal 498 (2024): 155643.

[114] F. Gao, W. Liang, Q. Chen, et al., “A Curcumin-Decorated Nanozyme With ROS Scavenging and Anti-Inflammatory Properties for Neuroprotection,” Nanomaterials 14 (2024): 389.

[115] Q. Ding, S. Zhang, and J. S. Kim, “A Lysosomal-targeted Pt(II) Metallacycle for NIR-II Fluorescence Imaging Guided Highly Efficient Tumor Immunogenic Cell Death,” Science China Chemistry 67 (2024): 3508–3509.

[116] X. Wang, X. Qin, Y. Liu, et al., “Plasmonic Supramolecular Nanozyme-Based Bio-Cockleburs for Synergistic Therapy of Infected Diabetic Wounds,” Advanced Materials 36 (2024): 2411194.

[117] N. Mandakhbayar, Y. Ji, A. El-Fiqi, et al. Bioactive Materials 31 (2024): 298.

[118] S. Gui, W. Tang, Z. Huang, et al., “Ultrasmall Coordination Polymer Nanodots Fe-Quer Nanozymes for Preventing and Delaying the Development and Progression of Diabetic Retinopathy,” Advanced Functional Materials 33 (2023): 2300261.

[119] H. Shen, Y. Fu, F. Liu, et al., “AuCePt Porous Hollow Cascade Nanozymes Targeted Delivery of Disulfiram for Alleviating Hepatic Insulin Resistance,” Journal of Nanbiotechnology 22 (2024): 660.

[120] H. Yang, L. Xia, X. Ye, et al., “Ultrathin Niobium Carbide MXenzyme for Remedying Hypertension by Antioxidative and Neuroprotective Actions,” Angewandte Chemie International Edition 62 (2023): e202303539.

[121] Y. Sun, T. Xu, Y. Qian, et al., “NOS-Like Activity of CeO₂ Nanozymes Contributes to Diminishing the Vascular Plaques,” Journal of Nanbiotechnology 22 (2024): 12.

[122] S. Chen, X. Luo, R. Ma, et al., “Promotes M1-polarization and Diabetic Wound Healing Using Prussian Blue Nanozymes,” International Immunopharmacology 141 (2024): 113009.

[123] C. Pu, Y. Wang, H. Xiang, et al., “Zinc-based Polyoxometalate Nanozyme Functionalized Hydrogels for Optimizing the Hyperglycemic-Immune Microenvironment to Promote Diabetic Wound Regeneration,” Journal of Nanobiotechnology 22 (2024): 611.

[124] S. Jiang, D. Xie, Z. Hu, et al., “Enhanced Diabetic Wound Healing With Injectable Hydrogel Containing Self-assembling Nanozymes,” Journal of Controlled Release 372 (2024): 265–280.

[125] B. Shen, Z. Yan, Y. Wang, L. Zhu, Q. Zhao, and L. Jiang, “Nanozyme-chitosan-aerogel Immobilized Enzyme-driven Biocatalytic Cascade for Therapeutic Engineering of Diabetic Wounds,” Carbohydrate Polymers 347 (2025): 122690.

[126] L. Chen, S. Xing, Y. Lei, et al., “A Glucose-Powered Activatable Nanozyme Breaking pH and H₂ O₂ Limitations for Treating Diabetic Infections,” Angewandte Chemie International Edition 60 (2021): 23534–23539.

[127] M. Tian, Z. Li, S. Liu, et al., “Ultrasmall Copper Nanodots Eye Drops for Microenvironment Regulation of Diabetes Retinopathy by Relieving Hypoxia and Inhibiting HIF-1α/VEGF Signaling Pathway,” Chemical Engineering Journal 491 (2024): 152130.

[128] L. Zhou, K. Lan, X. Huang, et al., “A Novel Photosynthetic Biohybrid System for Microenvironment Regulation of Diabetes Retinopathy Through Continuous Oxygen Supply and Nanozyme Cascade Reaction,” Advanced Functional Materials 33 (2023): 2302493.

[129] L. Argaev-Frenkel and T. Rosenzweig, “Redox Balance in Type 2 Diabetes: Therapeutic Potential and the Challenge of Antioxidant-Based Therapy,” Antioxidants 12 (2023): 994.

[130] Z. Wang, Y. Zhang, S. Chen, et al., “Multifunctional CeO₂ Nanozymes for Mitigating High-glucose Induced Senescence and Enhancing Bone Regeneration in Type 2 Diabetes Mellitus,” Chemical Engineering Journal 485 (2024): 149842.

[131] X. Li, W. Zhu, R. Liu, G. Ding, and H. Huang, “Cerium Oxide Nanozymes Improve Skeletal Muscle Function in Gestational Diabetic Offspring by Attenuating Mitochondrial Oxidative Stress,” ACS Omega 9 (2024): 21851–21863.

[132] Y. Lin, Y. Wang, Q. Zhang, et al., “Single-Atom Ce-N-C Nanozyme Ameliorates Type 2 Diabetes Mellitus by Improving Glucose Metabolism Disorders and Reducing Oxidative Stress,” Biomolecules 14 (2024): 1193.

[133] A. F. Prado, R. I. M. Batista, J. E. Tanus-Santos, and R. F. Gerlach, “Matrix Metalloproteinases and Arterial Hypertension: Role of Oxidative Stress and Nitric Oxide in Vascular Functional and Structural Alterations,” Biomolecules 11 (2021): 585.

[134] Q. Su, V. Kumar, N. Sud, and R. I. Mahato, “MicroRNAs in the Pathogenesis and Treatment of Progressive Liver Injury in NAFLD and Liver Fibrosis,” Advanced Drug Delivery Reviews 129 (2018): 54–63.

[135] D. Yang, K. Liu, C. Cai, et al., “Target-Engineered Liposomes Decorated With Nanozymes Alleviate Liver Fibrosis by Remodeling the Liver Microenvironment,” American Chemical Society Applied Materials & Interfaces 16 (2024): 64536–64553.

[136] Y. Li, Q. Li, Y. Zhu, et al., “Medicinal Plant-Derived Carbon Dots Nanozymes Ameliorate Ulcerative Colitis via Anti-inflammatory, Antioxidant, and Gut Barrier-Protective Effects,” American Chemical Society Applied Materials & Interfaces 17 (2025): 42751–42766.

[137] F. Dong, L. Hao, L. Wang, and Y. Huang, “Clickable Nanozyme Enhances Precise Colonization of Probiotics for Ameliorating Inflammatory Bowel Disease,” Journal of Controlled Release 373 (2024): 749–765.

[138] K. Jiang, X. Cao, H. Wu, et al., “2D Nanozymes Modulate Gut Microbiota and T-Cell Differentiation for Inflammatory Bowel Disease Management,” Advanced Healthcare Materials 13 (2023): 2302576.

[139] C.-P. J. Wang, G. R. Ko, Y. Y. Lee, et al., “Polymeric DNase-I Nanozymes Targeting Neutrophil Extracellular Traps for the Treatment of Bowel Inflammation,” Nano Convergence 11 (2024): 6.

[140] D. Zhu, H. Wu, K. Jiang, et al., “Zero-Valence Selenium-Enriched Prussian Blue Nanozymes Reconstruct Intestinal Barrier Against Inflammatory Bowel Disease via Inhibiting Ferroptosis and T Cells Differentiation,” Advanced Healthcare Materials 12 (2023): 2203160.

[141] Y. Zhang, H. Lei, P. Wang, et al., “Restoration of Dysregulated Intestinal Barrier and Inflammatory Regulation Through Synergistically Ameliorating Hypoxia and Scavenging Reactive Oxygen Species Using Ceria Nanozymes in Ulcerative Colitis,” Biomaterials Research 27 (2023): 75.

[142] F. Zeng, Y. Shi, C. Wu, et al., “A Drug-free Nanozyme for Mitigating Oxidative Stress and Inflammatory Bowel Disease,” Journal of Nanbiotechnology 20 (2022): 107.

[143] L. W. Peterson and D. Artis, “Intestinal Epithelial Cells: Regulators of Barrier Function and Immune Homeostasis,” Nature Reviews Immunology 14 (2014): 141–153.

[144] D. Zhang, H. Wan, R. Zhao, Y. Zhang, and H. Chen, “Eudragit S100 Coated Iron Oxide-chitosan Nanocomposites for Colon Targeting of 5-aminosalicylic Acid Ameliorate Ulcerative Colitis by Improving Intestinal Barrier Function and Inhibiting NLRP3 Inflammasome,” International Immunopharmacology 139 (2024): 112661.

[145] X. Jiang, Q. Yao, X. Xia, et al., “Self-assembled Nanoparticles With Bilirubin/JPH203 Alleviate Imiquimod-induced Psoriasis by Reducing Oxidative Stress and Suppressing Th17 Expansion,” Chemical Engineering Journal 431 (2022): 133956.

[146] H. Zhao, H. Zhao, M. Li, et al., “Twin Defect-rich Pt Ultrathin Nanowire Nanozymes Alleviate Inflammatory Skin Diseases by Scavenging Reactive Oxygen Species,” Redox Biology 70 (2024): 103055.

[147] L. Wu, G. Liu, W. Wang, et al., “Cyclodextrin-Modified CeO<Sub>2</Sub> Nanoparticles as a Multifunctional Nanozyme for Combinational Therapy of Psoriasis,” International Journal of Nanomedicine 15 (2020): 2515–2527.

[148] H. Xue, H. Zeng, S. Zhou, et al., “Polydopamine-coated Chondroitin Sulfate Methacryloyl Multifunctional Microspheres for Wound Treatment,” International Journal of Biological Macromolecules 280 (2024): 136087.

[149] D. Yang, M. Yuan, J. Huang, et al., “Conjugated Network Supporting Highly Surface-Exposed Ru Site-Based Artificial Antioxidase for Efficiently Modulating Microenvironment and Alleviating Solar Dermatitis,” ACS Nano 18 (2024): 3424–3437.

[150] X. Lu, L. Kuai, F. Huang, et al., “Single-atom Catalysts-based Catalytic ROS Clearance for Efficient Psoriasis Treatment and Relapse Prevention via Restoring ESR1,” Nature Communications 14 (2023): 6767.

[151] H. Cui, X. Zhang, Z. Zhang, et al., “Killing Three Birds With One Stone: Tumor-membrane-decorated Prussian Blue Nanovaccines for Synergistic Management of Skin Tumors, Radiation Dermatitis and Wounds,” Composites Part B Engineering 264 (2023): 110900.

[152] Z. Sun, H. Liu, M. Yin, et al., “Ruthenium Nanozyme@Magnesium Silicate Nanosheets Encapsuled in Microneedle Patches Promote Repair of Radiation-Induced Skin Defects by Remodeling Pathological Environment,” Interdisciplinary Medicine 3 (2025): e20240124.

[153] D. Zhou, M. Du, H. Luo, et al., “Multifunctional Mesoporous Silica-cerium Oxide Nanozymes Facilitate miR129 Delivery for High-quality Healing of Radiation-induced Skin Injury,” Journal of Nanbiotechnology 20 (2022): 409.

[154] H. Yao and I. Rahman, “Current Concepts on Oxidative/Carbonyl Stress, Inflammation and Epigenetics in Pathogenesis of Chronic Obstructive Pulmonary Disease,” Toxicology and Applied Pharmacology 254 (2011): 72–85.

[155] S.-B. He, L.-Y. Shi, Q.-H. Zheng, Y. Zhang, W. Chen, and Y.-M. Zeng, “Advances and Perspectives of Nanozymes in respiratory Diseases,” Journal of Materials Chemistry B 11 (2023): 7041–7054.

[156] S. Rajasekaran, N. Rajasekar, and A. Sivanantham, “Therapeutic Potential of Plant-derived Tannins in Non-malignant respiratory Diseases,” Journal of Nutritional Biochemistry 94 (2021): 108632.

[157] S. Lin, Y. Cheng, H. Zhang, et al., “Copper Tannic Acid Coordination Nanosheet: A Potent Nanozyme for Scavenging ROS From Cigarette Smoke,” Small 16 (2019): 1902123.

[158] M. Yin, D. Lei, Y. Liu, et al., “NIR Triggered Polydopamine Coated Cerium Dioxide Nanozyme for Ameliorating Acute Lung Injury via Enhanced ROS Scavenging,” Journal of Nanbiotechnology 22 (2024): 321.

[159] R. Yuan, Y. Li, S. Han, et al., “Fe-Curcumin Nanozyme-Mediated Reactive Oxygen Species Scavenging and Anti-Inflammation for Acute Lung Injury,” ACS Central Science 8 (2021): 10–21.

[160] C. Liu, W. Fan, W. X. Cheng, et al., “Red Emissive Carbon Dot Superoxide Dismutase Nanozyme for Bioimaging and Ameliorating Acute Lung Injury,” Advanced Functional Materials 33 (2023): 2213856.

[161] Q. Shen, M. Cao, C. Yu, et al., “Biodegradable Mesoporous Organosilica-Based Nanostabilizer Targeting Mast Cells for Long-Term Treatment of Allergic Diseases,” ACS Nano 18 (2024): 16934–16946.

[162] S. Ali, S. Sikdar, S. Basak, et al., “Label-Free Detection of Epinephrine Using Flower-Like Biomimetic CuS Antioxidant Nanozymes,” Inorganic Chemistry 62 (2023): 11291–11303.

[163] W. Yang, H. Yuan, H. Sun, et al., “Co-Mn Complex Oxide Nanoparticles as Potential Reactive Oxygen Species Scavenging Agents for Pulmonary Fibrosis Treatment,” Molecules 29 (2024): 5106.

[164] H. Ji, C. Zhang, F. Xu, et al., “Inhaled Pro-Efferocytic Nanozymes Promote Resolution of Acute Lung Injury,” Advanced Science 9 (2022): 2201696.

[165] K. Y. Wong, M. S. Wong, and J. Liu, “Nanozymes for Treating Ocular Diseases,” Advanced Healthcare Materials 14 (2024): 2401309.

[166] H. Zou, H. Wang, B. Xu, L. Liang, L. Shen, and Q. Lin, “Regenerative Cerium Oxide Nanozymes Alleviate Oxidative Stress for Efficient Dry Eye Disease Treatment,” Regener Biomater 9 (2022): rbac070.

[167] H. Zou, Y. Hong, B. Xu, M. Wang, H. Xie, and Q. Lin, “Multifunctional Cerium Oxide Nanozymes With High Ocular Surface Retention for Dry Eye Disease Treatment Achieved by Restoring Redox Balance,” Acta Biomaterialia 185 (2024): 441–455.

[168] W. Zhang, M. Zhao, D. Chu, et al., “Dual-ROS-scavenging and Dual-lingering Nanozyme-based Eye Drops Alleviate Dry Eye Disease,” Journal of Nanbiotechnology 22 (2024): 229.

[169] H. Zou, Y. Hong, B. Xu, et al., “Multifunctional Cerium Oxide Nanozyme for Synergistic Dry Eye Disease Therapy,” ACS Applied Materials & Interfaces 16 (2024): 34757–34771.

[170] W. Wei, H. Cao, D. Shen, X. Sun, Z. Jia, and M. Zhang, “Antioxidant Carbon Dots Nanozyme Loaded in Thermosensitive in Situ Hydrogel System for Efficient Dry Eye Disease Treatment,” International Journal of Nanomedicine 19 (2024): 4045–4060.

[171] Y. Jin, D. Cai, L. Mo, et al., “Multifunctional Nanogel Loaded With Cerium Oxide Nanozyme and CX3CL1 Protein: Targeted Immunomodulation and Retinal Protection in uveitis Rat Model,” Biomaterials 309 (2024): 122617.

[172] Z. Chen, Z. Li, N. Tang, et al., “Engineering Ultra-Small Cerium-Based Metal–Organic Frameworks Nanozymes for Efficient Antioxidative Treatment of Dry Eye Disease,” Advanced Functional Materials 34 (2023): 2307569.

[173] S. Liu, Q. Bai, Y. Jiang, et al., “Multienzyme-like Nanozyme Encapsulated Ocular Microneedles for Keratitis Treatment,” Small 20 (2023): 2308403.

[174] O. A. Kost, O. V. Beznos, N. G. Davydova, et al., “Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation,” Oxidative Medicine and Cellular Longevity 2016 (2015): 5194239.

[175] Z. Jiang, K. Liang, X. Gao, et al., “Fe-curcumin Nanozyme-mediated Immunosuppression and Anti-inflammation in Experimental Autoimmune Uveitis,” Biomaterials Research 27 (2023): 131.

[176] J. Zhao, Y. Wang, Y. Zhang, X. Guo, H. Bao, and Y. Tao Advanced Healthcare Materials (2024): 2402523.

[177] D. Chu, M. Zhao, S. Rong, et al., “Dual-Atom Nanozyme Eye Drops Attenuate Inflammation and Break the Vicious Cycle in Dry Eye Disease,” Nano-Micro Letters 16 (2024): 120.

[178] X. Sun, X. Xu, X. Yue, et al., “Nanozymes with Osteochondral Regenerative Effects: An Overview of Mechanisms and Recent Applications,” Advanced Healthcare Materials 13 (2023): 2301924.

[179] P. Yu, Y. Li, H. Sun, et al., “Mimicking Antioxidases and Hyaluronan Synthase: A Zwitterionic Nanozyme for Photothermal Therapy of Osteoarthritis,” Advanced Materials 35 (2023): 2303299.

[180] H. Yang, D. Lu, Z. Liu, Y. Xu, Y. Niu, and C. Liu, “pH‑Responsive Nanozyme Cascade Catalysis: A Strategy of BiVO4 Application for Modulation of Pathological Wound Microenvironment,” Journal of Colloid & Interface Science 674 (2024): 29–38.

[181] Y. Li, J. Yang, X. Chen, et al., “Mitochondrial-targeting and NIR-responsive Mn3O4@PDA@Pd-SS31 Nanozymes Reduce Oxidative Stress and Reverse Mitochondrial Dysfunction to Alleviate Osteoarthritis,” Biomaterials 305 (2024): 122449.

[182] Q. W. Chen, M. W. Cao, J. Y. Qiao, Q. R. Li, and X. Z. Zhang, “Integrated Cascade Catalysis of Microalgal Bioenzyme and Inorganic Nanozyme for Anti-inflammation Therapy,” Nanoscale Horizons 8 (2023): 489–498.

[183] Y. Wang, X. He, K. Huang, and N. Cheng, “Nanozyme as a Rising Star for Metabolic Disease Management,” Journal of Nanbiotechnology 22 (2024): 226.

[184] S. Gu and C. Ran, “Advanced Optical Microscopic Imaging Techniques for Imaging Amyloid Beta and Deciphering Alzheimer's Disease Pathogenesis,” Iradiology 3 (2025): 95–114.

[185] Y. Huang, L. Jia, S. Zhang, L. Yan, and L. Li, “Bimetallic Doped Carbon Dot Nanozymes for Enhanced Sonodynamic and Nanocatalytic Therapy,” Journal of Materials Chemistry B 13 (2025): 588–598.

[186] J. Zhou, D. Shi, T. Kaneko, W. Dong, and M. Chen, “Bioinspired Mineralization of Ultra-Small Ceria on Cellulose Nanofiber Enables Biocompatible and Efficient Nanozyme,” Carbohydrate Polymers 348 (2025): 122938.

[187] H. Li, Z. Liu, P. Zhang, and D. Zhang, “The Recent Research Progress in the Application of the Nanozyme-Hydrogel Composite System for Drug Delivery,” Drug Delivery 31 (2024): 2417986.

[188] M. Gao, X. Liu, Z. Wang, et al., “Engineering Catalytic Dephosphorylation Reaction for Endotoxin Inactivation,” Nano Today 44 (2022): 101456.

[189] Z. Chen, J.-J. Yin, Y.-T. Zhou, et al., “Dual Enzyme-Like Activities of Iron Oxide Nanoparticles and Their Implication for Diminishing Cytotoxicity,” ACS Nano 6 (2012): 4001–4012.

[190] B. Wang, Y. Fang, X. Han, et al., “Atomization-Induced High Intrinsic Activity of a Biocompatible MgAl-LDH Supported Ru Single-Atom Nanozyme for Efficient Radicals Scavenging,” Angewandte Chemie International Edition 62 (2023): e202307133.

[191] Y. Bai, Y. Li, Y. Li, and L. Tian, “Cell-Based Therapy for Degenerative Retinal Disease Advanced Biological Applications of Cerium Oxide Nanozymes in Disease Related to Oxidative Damage,” ACS Omega 9 (2024): 8601–8614.

[192] X. Han, H. Akifumi, P. Lv, et al., “Low-Intensity Focused Ultrasound Ameliorates Cisplatin-Induced Cognitive Impairment by Attenuating Hippocampal Neuroinflammation and Enhancing Synaptic Plasticity in Rats,” Iradiology 3 (2025): 152–167.

[193] D. Wang, Q. Li, C. Xiao, H. Wang, and S. Dong, “Nanoparticles in Periodontitis Therapy: A Review of the Current Situation,” International Journal of Nanomedicine 19 (2024): 6857–6893.

[194] Q. Liu, A. Zhang, R. Wang, Q. Zhang, and D. Cui, “A Review on Metal- and Metal Oxide-Based Nanozymes: Properties, Mechanisms, and Applications,” Nano-Micro Letters 13 (2021): 154.

[195] H. Dong, W. Du, J. Dong, et al., “Depletable Peroxidase-Like Activity of Fe₃O₄ Nanozymes Accompanied With Separate Migration of Electrons and Iron Ions,” Nature Communications 13 (2022): 5365.

[196] N. Kajarabille and G. O. Latunde-Dada, “Programmed Cell-Death by Ferroptosis: Antioxidants as Mitigators,” International Journal of Molecular Sciences 20 (2019): 4968.

[197] U. S. Patil, S. Adireddy, A. Jaiswal, S. Mandava, B. R. Lee, and D. B. Chrisey, “In Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide Nanoparticles,” International Journal of Molecular Sciences 16 (2015): 24417–24450.

[198] C. Dai, R. Hu, S. Cao, et al., “Mesoporous Ternary Nanozymes With Anti-Senescence and Anti-Inflammation Activities for Atherosclerosis Management,” Advanced Functional Materials 34 (2024): 2313646.

[199] D. Zhang, Q. Chen, Q. Ren, et al., “Transition Metal-Based Nanozymes: Classification, Catalytic Mechanisms and Emerging Biomedical Applications,” Coordination Chemistry Reviews 508 (2024): 215771.

[200] M. A. Younis, H. M. Tawfeek, A. A. H. Abdellatif, J. A. Abdel-Aleem, and H. Harashima, “Clinical Translation of Nanomedicines: Challenges, Opportunities, and Keys,” Advanced Drug Delivery Reviews 181 (2022): 114083.

[201] L. Chen, S.-L. Chen, Y. Yuan, et al., “Complexity Made Easy: Aggregation-Induced Emission Small Molecules for Cancer Diagnosis and Phototherapies,” Aggregate 5 (2024): e657.

[202] J. Chen, X. Zheng, J. Zhang, et al., “Bubble-templated Synthesis of Nanocatalyst Co/C as NADH Oxidase Mimic,” National Science Review 9 (2022): nwab186.

[203] W. He, J. Wu, J. Liu, and J. Li, “Single-Atom Nanozymes for Catalytic Therapy: Recent Advances and Challenges,” Advanced Functional Materials 34 (2024): 2312116.

[204] D. W. Losito, N. I. N. Souza, T. S. Martins, T. N. Britos, M. L. Schumacher, and P. S. Haddad, “A Review of Superparamagnetic Nanoparticles Applications and Regulatory Aspects in Medicine and Environmental Areas,” Journal of Materials Science 59 (2024): 16038–16068.

[205] N. Saravanan, P. Ganesh, S. Pitchaimuthu, and A. Sundaramurthy, “Nanozyme Controlled Photothermal Heat Generation on Nanoceria Decorated MoS2 Nanoflowers for Enhanced Cytotoxicity in Cancer Chemo-photothermal Therapy,” Surf Interfaces 41 (2023): 103225.

[206] X. Wu, Y. Zhang, P. Xing, and M. Zhu, “Surface Functionalization Strategies of ROS-Scavenging Nanozymes for Synergistic Therapy and Efficient Delivery,” Journal of Materials Chemistry B 13 (2025): 7653–7667.

[207] Z. Yu, L. Huang, and J. Guo, “Anti-Stromal Nanotherapeutics for Hepatocellular Carcinoma,” Journal of Controlled Release 367 (2024): 500–514.

[208] B. Fury, H. Klassen, and G. Bauer, “Manufacturing of Clinical Grade Cellular Products Under GMP Conditions,” Cell-Based Therapy for Degenerative Retinal Disease (2019): 81–95.

[209] H.-Q. Zhan, X. Zhang, X.-L. Chen, L. Cheng, and X. Wang, “Application of Nanotechnology in the Treatment of Glomerulonephritis: Current Status and Future Perspectives,” Journal of Nanbiotechnology 22 (2024): 9.

[210] J. P. Gibbs, R. Menon, and S. Kasichayanula, “Bedside to Bench: Integrating Quantitative Clinical Pharmacology and Reverse Translation to Optimize Drug Development,” Clinical Pharmacology & Therapeutics 103 (2017): 196–198.

[211] Q. Hu, H. Zuo, J. C. Hsu, et al., “The Emerging Landscape for Combating Resistance Associated With Energy-Based Therapies via Nanomedicine,” Advanced Materials 36 (2023): 2308286.

[212] Z. Chen, Y. Yu, Y. Gao, and Z. Zhu, “Rational Design Strategies for Nanozymes,” ACS Nano 17 (2023): 13062–13080.

[213] Y. Wei, J. Wu, Y. Wu, et al., “Prediction and Design of Nanozymes Using Explainable Machine Learning,” Advanced Materials 34 (2022): 2201736.

[214] L. Luo, Q. Liu, Y. Zhang, et al., “Precisely Edited Gut Microbiota by Tungsten-Doped Prussian Blue Nanoparticles for the Treatment of Inflammatory Bowel Disease,” Journal of Controlled Release 382 (2025): 113755.

[215] Q.-X. Huang, J.-L. Liang, C.-H. Yang, et al., “Stimulation-Responsive Mucoadhesive Probiotics for Inflammatory Bowel Disease Treatment by Scavenging Reactive Oxygen Species and Regulating Gut Microbiota,” Biomaterials 301 (2023): 122274.

[216] L. Zhu, J. Liu, G. Zhou, et al., “Remodeling of Tumor Microenvironment by Tumor-Targeting Nanozymes Enhances Immune Activation of CAR T Cells for Combination Therapy,” Small 17 (2021): 2102624.

[217] Q. Liu, J. Tian, J. Liu, et al., “Modular Assembly of Tumor-Penetrating and Oligomeric Nanozyme Based on Intrinsically Self-Assembling Protein Nanocages,” Advanced Materials 33 (2021): 2103128.

[218] G. Sun, K. Sun, and J. Sun, “Combination Prostate Cancer Therapy: Prostate-Specific Membranes Antigen Targeted, pH-sensitive Nanoparticles Loaded With Doxorubicin and Tanshinone,” Drug Delivery 28 (2021): 1132–1140.

[219] Z. Chen, Z. Li, N. Tang, et al., “Engineering Ultra-Small Cerium-Based Metal–Organic Frameworks Nanozymes for Efficient Antioxidative Treatment of Dry Eye Disease,” Advanced Functional Materials 34 (2024): 2307569.

[220] Y. Chen, Y. Wang, Z. Chen, et al., “NIR-driven Polydopamine-based Nanoenzymes as ROS Scavengers to Suppress Osteoarthritis Progression,” Mater Today Nano 19 (2022): 100240.

[221] J. Xu, M. Wu, J. Yang, et al., “Multimodal Smart Systems Reprogramme Macrophages and Remove Urate to Treat Gouty Arthritis,” Nature Nanotechnology 19 (2024): 1544–1557.

[222] Y. Liu, B. Wang, J. Zhu, X. Xu, B. Zhou, and Y. Yang, “Single-Atom Nanozyme With Asymmetric Electron Distribution for Tumor Catalytic Therapy by Disrupting Tumor Redox and Energy Metabolism Homeostasis,” Advanced Materials 35 (2023): 2208512.

[223] L. Na and F. Fan, “Advances in Nanobubbles for Cancer Theranostics: Delivery, Imaging and Therapy,” Biochemical Pharmacology 226 (2024): 116341.

[224] W. Liu, D. Liu, and M. Liu, “Effects of Process Parameters on Preparation of Ti@SiO2 Particles During Fluidized Bed Chemical Vapor Deposition via Design of Experiments,” Chemical Engineering Research and Design 187 (2022): 425–433.

[225] H. Li and Y. Huang, “Expression of Brown-midrib in a Spontaneous Sorghum Mutant Is Linked to a 5′-UTR Deletion in Lignin Biosynthesis Gene SbCAD2,” Scientific Reports 7 (2017): 11664.

[226] J. Liu, J. Wei, S. Xiao, et al., “Multienzyme-Activity Sulfur Quantum Dot Nanozyme-Mediated Cascade Reactions in Whole-Stage Symptomatic Therapy of Infected Bone Defects,” ACS Nano 19 (2025): 6858–6875.

[227] S. Wang, X. Liu, Y. Wu, et al., “Defect-engineered Sonopiezoelectric Nanosheets Enable Sacrificial-agent-free Hydrogen Peroxide Self-cycling for Enhanced Pancatalytic Therapy,” Cell Biomaterials (2025): 100101.

[228] H. Huang and Y. Chen, “Catalytic Biomaterials, Catalytic Biology and Catalytic Medicine,” Science Bulletin 70 (2025): 1554–1558.

[229] Y. Zhai, S. Pei, X. Qin, et al., “Ultralow Dose Iron-Copper Bimetallic Single-Atom Nanozymes for Efficient Photothermal-Chemodynamic Antibacterial and Wound Healing,” Advanced Healthcare Materials 14 (2024): 2403920.

[230] R. Zhang, B. Jiang, K. Fan, L. Gao, and X. Yan, “Designing Nanozymes for in Vivo Applications,” Nature Reviews Bioengineering 2 (2024): 849–868.

[231] X. Wu, H. Guo, H. Gao, et al., “Peptide Targeting Improves the Delivery and Therapeutic Index of Glucocorticoids to Treat Rheumatoid Arthritis,” Journal of Controlled Release 368 (2024): 329–343.

[232] Y. Cheng, Y. Zhang, Z. Zhao, et al., “Guanidinium-Decorated Nanostructure for Precision Sonodynamic-Catalytic Therapy of MRSA-Infected Osteomyelitis,” Advanced Materials 34 (2022): 220646.

[233] Q. Zhao, L. Wang, R. Cheng, et al., “Magnetic Nanoparticle-Based Hyperthermia for Head & Neck Cancer in Mouse Models,” Theranostics 2 (2012): 113–121.

[234] T. A. Tabish, M. J. Crabtree, H. E. Townley, P. G. Winyard, and C. A. Lygate, “Nitric Oxide Releasing Nanomaterials for Cardiovascular Applications,” JACC: Basic to Translational Science 9 (2024): 691.

[235] J. Hou, R. Fu, T. Yu, et al., “Synergistic Antibacterial Therapy for Multidrug-resistant Bacterial Infections Using Multifunctional Nanozymes,” Nano Today 54 (2024): 102118.

[236] Y. Guo, Z. Lv, Y. Zhang, et al., “Covalent Multi-targeted Radiopharmaceuticals for Enhanced Tumor Theranostics,” Science China Chemistry 68 (2025): 1456–1467.

[237] Y. Feng, Z. Cheng, A.-K. K. Larsen, et al., “Amyloid-Like Nanofibrous Network Confined and Aligned Ultrafine Bimetallic Nanozymes for Smart Antibacterial Therapy,” Materials Today Bio 22 (2023): 100730.

RIGHTS & PERMISSIONS

2025 The Author(s). Aggregate published by SCUT, AIEI and John Wiley & Sons Australia, Ltd.